Anaveon is a late pre-clinical phase biotech based in Basel, Switzerland. It focuses on the development of next generation IL-2 based therapeutic antibodies for tumor immunotherapy in melanoma, kidney carcinoma and lung cancer.
- News
- Events
- The industry
arrow_drop_down
- Association
arrow_drop_down
-
Swiss Biotech AssociationMember
- Claim listing
Location
Facts & figures
-
Type of organizationPrivate company
-
Year of foundation2017